News
CCM Biosciences Announces Presentation of Data on its First-In-Class NSCLC Drug Program at ASCO 2025
CCM Biosciences, a diversified pharmaceutical discovery and development company, today announced the upcoming presentation of its 4th-generation EGFR inhibitor drug program for non-small cell lung ...
This graduation season, 26 Edina residents have a deeper understanding of and appreciation for their local government after graduating from the “Edina U” program. Edina U was developed to provide an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results